GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yonghe Medical Group Co Ltd (FRA:L97) » Definitions » Beneish M-Score

Yonghe Medical Group Co (FRA:L97) Beneish M-Score : -3.01 (As of Jun. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Yonghe Medical Group Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.01 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Yonghe Medical Group Co's Beneish M-Score or its related term are showing as below:

FRA:L97' s Beneish M-Score Range Over the Past 10 Years
Min: -3.1   Med: -2.83   Max: -2.45
Current: -3.01

During the past 6 years, the highest Beneish M-Score of Yonghe Medical Group Co was -2.45. The lowest was -3.10. And the median was -2.83.


Yonghe Medical Group Co Beneish M-Score Historical Data

The historical data trend for Yonghe Medical Group Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yonghe Medical Group Co Beneish M-Score Chart

Yonghe Medical Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - -3.10 -2.65 -2.45 -3.01

Yonghe Medical Group Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.65 - -2.45 - -3.01

Competitive Comparison of Yonghe Medical Group Co's Beneish M-Score

For the Medical Care Facilities subindustry, Yonghe Medical Group Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yonghe Medical Group Co's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Yonghe Medical Group Co's Beneish M-Score falls into.



Yonghe Medical Group Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Yonghe Medical Group Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1758+0.528 * 1.1008+0.404 * 1.5884+0.892 * 1.1932+0.115 * 0.6598
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1686+4.679 * -0.216496-0.327 * 1.3344
=-3.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was €2.2 Mil.
Revenue was €228.2 Mil.
Gross Profit was €128.1 Mil.
Total Current Assets was €103.9 Mil.
Total Assets was €314.0 Mil.
Property, Plant and Equipment(Net PPE) was €191.4 Mil.
Depreciation, Depletion and Amortization(DDA) was €43.0 Mil.
Selling, General, & Admin. Expense(SGA) was €107.0 Mil.
Total Current Liabilities was €92.8 Mil.
Long-Term Debt & Capital Lease Obligation was €99.2 Mil.
Net Income was €-70.2 Mil.
Gross Profit was €0.0 Mil.
Cash Flow from Operations was €-2.2 Mil.
Total Receivables was €1.6 Mil.
Revenue was €191.3 Mil.
Gross Profit was €118.2 Mil.
Total Current Assets was €161.1 Mil.
Total Assets was €396.8 Mil.
Property, Plant and Equipment(Net PPE) was €220.9 Mil.
Depreciation, Depletion and Amortization(DDA) was €30.4 Mil.
Selling, General, & Admin. Expense(SGA) was €76.7 Mil.
Total Current Liabilities was €67.5 Mil.
Long-Term Debt & Capital Lease Obligation was €114.4 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2.176 / 228.249) / (1.551 / 191.298)
=0.009533 / 0.008108
=1.1758

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(118.151 / 191.298) / (128.066 / 228.249)
=0.617628 / 0.56108
=1.1008

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (103.94 + 191.401) / 313.95) / (1 - (161.061 + 220.917) / 396.785)
=0.059274 / 0.037317
=1.5884

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=228.249 / 191.298
=1.1932

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(30.422 / (30.422 + 220.917)) / (43.003 / (43.003 + 191.401))
=0.12104 / 0.183457
=0.6598

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(107.006 / 228.249) / (76.742 / 191.298)
=0.468813 / 0.401165
=1.1686

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((99.235 + 92.841) / 313.95) / ((114.423 + 67.5) / 396.785)
=0.611804 / 0.458493
=1.3344

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-70.172 - 0 - -2.203) / 313.95
=-0.216496

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Yonghe Medical Group Co has a M-score of -3.05 suggests that the company is unlikely to be a manipulator.


Yonghe Medical Group Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Yonghe Medical Group Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Yonghe Medical Group Co (FRA:L97) Business Description

Traded in Other Exchanges
Address
11th Floor, 20 Ganluyuan Nanli, China Nuclear E&C Building, Chaoyang District, Beijing, CHN, 100020
Yonghe Medical Group Co Ltd is a medical group in China that specialized in providing hair-related healthcare services. It offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.

Yonghe Medical Group Co (FRA:L97) Headlines

No Headlines